![Michael Sweeney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Sweeney
Technik-/Wissenschafts-/F&E-Leiter bei
RESVERLOGIX CORP.
Vermögen: 10 406 $ am 30.06.2026
Profil
Dr. Michael T.
Sweeney, MD, is a Senior Vice President-Clinical Development at Resverlogix Corp.
Dr. Sweeney was previously employed as a Chief Medical Officer, VP-Research & Development by Depomed, Inc., a Vice President-Medical Affairs by CV Therapeutics, Inc., a Senior Director-Urology Global Medial Group Leader by Pfizer Inc., and a Senior Clinical Pharmacologist by Zeneca Group Plc.
He received his doctorate degree from The University of Liverpool.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
RESVERLOGIX CORP. 0.05% | 02.04.2025 | 155’312 ( 0.05% ) | 10 406 $ | 30.06.2026 |
Aktive Positionen von Michael Sweeney
| Unternehmen | Position | Beginn |
|---|---|---|
| RESVERLOGIX CORP. | Technik-/Wissenschafts-/F&E-Leiter | 03.11.2014 |
Ehemalige bekannte Positionen von Michael Sweeney
| Unternehmen | Position | Ende |
|---|---|---|
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2014 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2007 |
| PFIZER INC. | Corporate Officer/Principal | 01.01.2003 |
Zeneca Group Plc
 Zeneca Group Plc Pharmaceuticals: MajorHealth Technology Develops & manufactures pharmaceutical products, agrochemicals and speciality chemicals | Corporate Officer/Principal | - |
Ausbildung von Michael Sweeney
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
73
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Resverlogix Corp.
 Resverlogix Corp. Pharmaceuticals: MajorHealth Technology Engages in the research and development of novel biopharmaceuticals for the treatment of grievous diseases | Health Technology |
The University of Liverpool
 The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zeneca Group Plc
Zeneca Group Plc Pharmaceuticals: MajorHealth Technology Develops & manufactures pharmaceutical products, agrochemicals and speciality chemicals | Health Technology |
Wählen Sie MarketScreener 
